-+ 0.00%
-+ 0.00%
-+ 0.00%

SUMMIT THERAPEUTICS ANNOUNCES OPENING OF GLOBAL PHASE II STUDY OF IVONESCIMAB-BASED REGIMENS IN ADVANCED CLEAR CELL RENAL CELL CARCINOMA

Reuters·10/19/2026 11:02:54

Please log in to view news